Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing NaN - NaN of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular Trial in China (TACE containing As2O3, TACE containing )

Unknown status
  • Carcinoma, Hepatocellular
  • TACE containing As2O3
  • TACE containing placebo
  • Guangzhou, Guangdong, China
  • +4 more
May 25, 2014

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Hefei, Anhui, China
  • +22 more
Mar 26, 2014

Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)

Terminated
Has Results
  • Carcinoma, Hepatocellular
  • Fountain Valley, California
  • +170 more
Dec 7, 2012

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

Terminated
  • Hepatocellular Carcinoma Non-resectable
  • +12 more
  • Beverly Hills, California
  • +162 more
Sep 7, 2012

Carcinoma, Hepatocellular Trial in Worldwide (Oxaliplatin + 5-Fluorouracil/Leucovorin, Doxorubicin)

Completed
  • Carcinoma, Hepatocellular
  • Shanghai, China
  • +3 more
Sep 17, 2010

Carcinoma, Hepatocellular Trial in Worldwide (Irinotecan plus capecitabine)

Completed
  • Carcinoma, Hepatocellular
  • Irinotecan plus capecitabine
  • Shanghai, China
  • +8 more
Apr 2, 2008